SCHEMBL3032641

SCHEMBL3032641

Cc1ccc(-c2cccc(Br)c2)n1-c1ccc(S(=O)(=O)N2CCCCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MCOLN3 Q8TDD5 1/20 0.46
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
USP2 O75604 1/20 0.44
PKM P14618 1/20 0.44
MAPT P10636 1/20 0.43
PTGS2 P35354 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MBTD1 Q05BQ5 1/20 0.42
L3MBTL3 Q96JM7 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3024752 0.87 MEN1 (0.52) ALDH1A1GAAUSP2PKMMAPT
SCHEMBL3027933 0.79 L3MBTL1 (0.56) ALDH1A1USP2PKMPTGS2MEN1
SCHEMBL3033914 0.75 KMT2A (0.47) ALDH1A1GAAUSP2PKMMAPT
SCHEMBL3030118 0.74 L3MBTL1 (0.49) ALDH1A1USP2MAPTMEN1KMT2A
SCHEMBL3391959 0.72 MBTD1 (0.71) MCOLN3ALDH1A1GAAUSP2MAPT
SCHEMBL31689628 0.72 MBTD1 (0.71) MCOLN3ALDH1A1GAAUSP2MAPT
SCHEMBL265068 0.72 MBTD1 (0.71) MCOLN3ALDH1A1GAAUSP2MAPT
SCHEMBL263317 0.70 MBTD1 (0.73) MCOLN3ALDH1A1GAAUSP2MAPT
SCHEMBL3024630 0.69 PTGS2 (0.57) ALDH1A1PKMMAPTPTGS2
SCHEMBL709027 0.69 USP2 (0.80) ALDH1A1GAAUSP2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609713-B2 Pyrrole derivatives and their methods of use ABBVIE INC. (US) 2013-12-17 US disclosed
US-20100216748-A1 Pyrrole Derivatives and Their Methods of Use ABBOTT LABORATORIES (US) 2010-08-26 US disclosed
US-7741364-B2 Neuronal nicotinic acetylcholine receptor modulators; such as ethyl 1-[4-(aminosulfonyl)phenyl]-5-(4-bromophenyl)-2-methyl-1H-pyrrole-3-carboxylate ABBOTT LABORATORIES (US) 2010-06-22 US disclosed
US-20080064695-A1 PYRROLE DERIVATIVES AND THEIR METHODS OF USE ABBVIE INC. 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064695-A1 PYRROLE DERIVATIVES AND THEIR METHODS OF USE PYCR1, PPOX, DHPS MCOLN3 3212/4885ALDH1A1 745/4885GAA 2215/4885
US-20100216748-A1 Pyrrole Derivatives and Their Methods of Use PYCR1, PPOX, DHPS MCOLN3 3212/4885ALDH1A1 745/4885GAA 2215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.